A prospective randomized trial of two 14-day sequential therapies for Helicobacter pylori eradication

被引:0
|
作者
Chang, S-N [1 ,2 ]
Wu, D-C [3 ]
Wu, J-Y [3 ]
Lai, K-H [1 ,2 ]
Hsu, P-I [1 ,2 ]
机构
[1] Kaohsiung Vet Gen Hosp, Dept Internal Med, Div Gastroenterol, Kaohsiung, Taiwan
[2] Natl Yang Ming Univ, Kaohsiung, Taiwan
[3] Kaohsiung Med Univ Hosp, Dept Internal Med, Div Gastroenterol, Kaohsiung, Taiwan
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:A20 / A20
页数:1
相关论文
共 50 条
  • [31] Randomized clinical trial comparing 10-day sequential, 7-day concomitant and 7-day standard triple therapies for Helicobacter pylori eradication
    Tepes, Bojan
    Vujasinovic, Miroslav
    Seruga, Maja
    Stefanovic, Milan
    Forte, Alenka
    Jeverica, Samo
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2016, 28 (06) : 676 - 683
  • [32] Fourteen-day hybrid therapy achieves an excellent eradication rate as 14-day bismuth containing quadruple therapy for Helicobacter pylori infection: A randomized controlled trial
    Sun, W. C.
    Tsay, F. W.
    Yu, H. C.
    Wu, D. C.
    Hsu, P. I.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2015, 30 : 9 - 9
  • [33] Efficacy of 10-day VAL (Vonoprazan, Amoxicillin, and Levofloxacin) vs 14-day Standard Triple Therapy for Helicobacter pylori Eradication: A Multicenter Randomized Controlled Trial
    Sangsuwan, Suttigiat
    Suksamai, Anuchit
    Preechathammawong, Noppamate
    Songserm, Sukhum
    Opuchar, Krit
    Chirapongsathorn, Sakkarin
    Yongwatana, Kachonsak
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S): : S1621 - S1622
  • [34] A Modified 14-Day Dual Therapy with Vonoprazan and Amoxicillin Amplified the Advantages Over Conventional Therapies for Eradication of Helicobacter pylori: A Non-Inferiority Clinical Trial
    Li, Juan
    Lv, Lin
    Zhu, Yongjun
    Zhou, Zhihang
    He, Song
    INFECTION AND DRUG RESISTANCE, 2023, 16 : 5637 - 5645
  • [35] A Prospective, Randomized Study Comparing 7-day and 14-day Quadruple Therapies as First-line Treatments for Helicobacter pylori Infection in Patients with Functional Dyspepsia
    Yagbasan, A.
    Coskun, D. O.
    Ozbakir, O.
    Deniz, K.
    Gursoy, S.
    Yucesoy, M.
    NIGERIAN JOURNAL OF CLINICAL PRACTICE, 2018, 21 (01) : 54 - 58
  • [36] HIGH EFFICACY OF 14-DAY VONOPRAZAN-BASED QUADRUPLE THERAPY FOR HELICOBACTER PYLORI ERADICATION IN AREAS WITH HIGH CLARITHROMYCIN RESISTANCE: A PROSPECTIVE RANDOMIZED STUDY (VQ-HP TRIAL)
    Tungtrongchitr, Nuttapat
    Pornthisarn, Bubpha
    Chonprasertsuk, Soonthorn
    Siramolpiwat, Sith
    Bhanthumkomol, Patommatat
    Nunanan, Pongjarat
    Issariyakulkarn, Navapan
    Mahachai, Varocha
    Vilaichone, Ratha-Korn
    GASTROENTEROLOGY, 2022, 162 (07) : S871 - S871
  • [37] A Randomized Trial Comparing 14-Day Triple, 10-Day Sequential, and 5-Day Concomitant Therapy to Eradicate Helicobacter pylori in Seven Latin American Populations
    Ferreccio, Catterina
    Anderson, Garnet L.
    Morgan, Douglas R.
    Torres, Javier
    Bravo, Luis Eduardo
    Dominguez, Ricardo
    Herrero, Rolando
    Meza-Montenegro, Mercedes
    Pena, Rodolfo
    Salazar-Martinez, Eduardo
    Chey, William D.
    Valdivieso, Manuel
    Crowley, John
    Goodman, Gary E.
    Greenberg, E. Robert
    Baker, Laurence H.
    GASTROENTEROLOGY, 2011, 140 (05) : S137 - S137
  • [38] Clinical Outcomes of Two-Week Sequential and Concomitant Therapies for Helicobacter pylori Eradication: A Randomized Pilot Study
    Lim, Ji Hyun
    Lee, Dong Ho
    Choi, Chiun
    Lee, Seong Tae
    Kim, Nayoung
    Jeong, Sook Hyang
    Kim, Jin Wook
    Hwang, Jin Hyeok
    Park, Young Soo
    Lee, Sang Hyub
    Shin, Cheol Min
    Jo, Hyun Jin
    Jang, Eun Sun
    Song, In Sung
    Jung, Hyun Chae
    HELICOBACTER, 2013, 18 (03) : 180 - 186
  • [39] Efficacy of sequential therapy for Helicobacter pylori eradication in Bangladesh: a randomized controlled trial
    Ahmad, M. M.
    Kibria, M. G.
    Rahman, M. M.
    Masud, M. A.
    Sarker, A. R.
    Ahasan, K.
    Hasan, M.
    Khann, A. K. Azad
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2010, 25 : A158 - A158
  • [40] Feasibility of Shortening 14-day Hybrid Therapy While Maintaining an Excellent Helicobacter pylori Eradication Rate
    Wu, Jeng-Yih
    Hsu, Ping-I
    Wu, Deng-Chyang
    Graham, David Y.
    Wang, Wen-Ming
    HELICOBACTER, 2014, 19 (03) : 207 - 213